SUMMARY In an epidemiological survey in Troms0, northern Norway a prevalence of definite ankylosing spondylitis (AS) of between 1-1% and 1-4% was found (males: 1 9-2 2% and females: 0-3-0.6%). The ratio of male to female was between 3 9 and 6-1 in favour of the male sex. It was calculated that 6-7% of the B27 positive individuals had AS, and that 22-5% of the B27 positive subjects with back pain or stiffness suffered from AS.
Ankylosing spondylitis (AS) has traditionally been considered a rather rare disease. Autopsy studies from 1932 and 19361 2 suggested a prevalence as low as 0.07-0-10%. In 1949 West3 proposed a prevalence of 005%, based on calculations of hospitalised cases of AS in Bristol, England. A marked variation in the geographic distribution of AS was shown by Gofton showed a male to female ratio of 5:1.
The association between AS and the histocompatibility antigen HLA-B27 is well established. '3 14 There are, however, conflicting opinions with regard to the frequency of AS in B27 positive
Accepted for publication 20 November 1984. Correspondence to: Dr J T Gran, Lillehammer Sanitetsforenings Revmatismesykehus, 2600 Lillehammer, Norway.
persons,'2 1517 and population studies are clearly needed to obtain reliable information about the absolute risk for B27 positive persons to have and to get AS. The aims of the present investigation were to determine the prevalence and the sex ratio of AS in Troms0, northern Norway by surveying a young middle-aged population of both sexes. Furthermore, we wanted to calculate the prevalence of AS in B27 positive persons, based on findings emerging from the same epidemiological survey.
Materials and methods

GEOGRAPHIC AND POPULATION CHARACTERISTICS
The municipality of Troms0 in northern Norway is located at a latitude of approximately 70°N. The population comprises three ethnic groups: La1pps (2.3%), Finns (4-7%), and Norsemen (93%).' In participate (female to male ratio 1:1.2). The main purpose of the study was to investigate possible risk factors connected with the development of car-00 r4 diovascular disorders.19 Of the 21 329 subjects invited to participate in the study 16 621 attended the screening (Table 1 ). All participants were given a questionnaire and they were instructed to fill in this questionnaire at home and return it by mail. fm The 14 539 participants who returned the questionnaire and answered the questions concerning back ->t 0 problems comprise the subjects of the present m analysis (responders). A non-responder was a subject who did not return the questionnaire or _r eturned it without answering the questions about back complaints. Except for a slightly higher age and number of females among responders as compared with non-responders to the questionnaire (Table 2) there were no fundamental differences between responders and non-responders. The questionnaire contained also three questions con-X -0 -> 0 cerning back pain ( Dale.2' these two groups were found with respect to spinal mobility, mean duration of morning stiffness, mean age, sex ratio, and duration of back pain.
The 375 films were read by a radiologist who was unaware of the clinical status of the patients. All films defined as grade I (suspicious changes) and grades II-V (definite changes) were then read blindly by a second radiologist. These films were mixed with 45 other randomly selected films (i.e. a total of 96 films) defined as normal ones (grade 0) by the first observer. Table 6 shows that a full agreement between the two observers was obtained in 74 of the x-rays (77.1%), while in eight films (8.3%) the two observers differed in the degree of Table 8 shows the estimated prevalence rates for AS in different age groups. When taking the back pain categories into account it was found that the prevalence rate increased with advancing age, the maximum prevalence 1-7%, being found in the age group of 50-54 years. A prevalence increasing with advancing age was not so pronounced when this possible sampling error was not considered (Table  8) .
FREQUENCY OF HLA-B27
Twenty out of 22 male AS patients (91%) and three of four (75%) female patients carried HLA-B27, the overall frequency of B27 being 88 5%.
FREQUENCY OF AS IN PERSONS CARRYING H LA-B27
The frequency of HLA-B27 in the general population of blood donors of Troms0 is 15 9%,2 and it was estimated that 6 7% of all B27 positive persons in the actual age groups had AS, the figures being 1-5% for females and 11 1% for males (Table 9 ). Of the B27 negative persons, 0-2% (0.1% of females and 0-2% of the males) had AS ( It was estimated that 209 cases of AS occurred among the 14 539 responders, and that of these 209 persons only 12 (6%) were known from the hospital records. Accordingly it could be concluded that of the total pool of AS in the Trosm0 population 94% of patients were not sufficiently ill to be seen at the hospital. Evidently this apparently very high nosocomial threshold for AS may have other explanations. One possible explanation is that some of the cases of AS admitted to the regional hospital of Troms0 were seen at the outpatient clinic only and were consequently not registered in the hospital files. Furthermore the Department of Rheumatology was started only in 1978, and many cases of AS might not have been referred to the department by the time of the epidemiological survey. On the other hand, in the study of Calin and coworkers27 only 6-3% of the patients with AS in an industrial complex were aware of the diagnosis, a figure strikingly similar to ours.
Clinical examination was performed by four observers, three of whom were last-year medical students, and all four examiners were aware of the fact that every respondent examined was a 'back complainer'. To establish a diagnosis of definite AS clinical evidence of the disease was required to support the radiological findings in only one out of 27 cases detected in the present survey. It was therefore unlikely that the clinical examination introduced observer biases which influenced the estimation of the prevalence of AS.
Furthermore it could be argued that the persons who did not show up for roentgenological examination were those with less severe back pain. When comparing these persons with those x-rayed, however, no convincing differences between the two groups emerged with respect to severity of back pain or other characteristics. Thus the calculated prevalence of 1-1-1-4% of definite AS may be quite close to the true prevalence of AS in our population.
The three questions of back pain used on the questionnaire were certainly not sufficiently specific to differentiate between inflammatory disorders and other more or less defined diseases of the back. Duration of back pain of more than three months instead of four weeks and an additional question about insidious onset of such pain would possibly have increased the specificity for AS, as suggested by Calin and coworkers." Thus our screening questions for AS presumably had a low specificity, as indicated by the low number of AS patients among those examined for back pain, but as a higher sensitivity would be expected by employing our questions, we do not believe that many cases of AS were missed.
Interpretation Another Norwegian study showed a prevalence of AS in males living in the southern part of the country of 0*17-0-31%. The study, however, was not comparable with our survey, as it was based on hospital records, and moreover, defined diagnostic criteria were not employed. Furthermore the prevalence of B27 in the general population of southern Norway (8-10%) is significantly lower than that of 15-9% in northern Norway. 22 A study by Kuberski and coworkers3' of the prevalence of AS in Navajo and Hopi Indians based on hospital records showed a prevalence of definite AS of 0-129%. However, as we previously noted26 and as clearly shown by Calin and coworkers27 the number of hospitalised patients with AS is rather low compared with the actual number of AS patients present in the population. Thus different prevalence rates obtained through hospital based studies and population surveys of AS may not reflect a real difference of the prevalence of AS in the general population.
The male dominance of AS was slightly less pronounced in this survey (3.9-6.1:1) than in most previous estimates, 1 12 32 33 which agreed with recent proposals that AS is not a rare disease in the female sex.3 On the other hand the recent proposals of an equal sex distribution of AS emerging through studies of blood donors,12 could not be supported by our results.
The prevalence of B27 among our AS patients was rather low (89%) as compared with other studies (92-100%). 13 34 35 This can be explained by the low number of AS patients found, as the prevalence of 89% was not statistically significantly different from the prevalence of B27 among our hospitalised patients, i.e., 95%. 26 Different studies of blood donors have estimated the risk of having AS for a B27 positive carrier to vary from 0.3% to 25%.12 15 16 36 The present epidemiological study concluded that there is a risk of 6-7% for a B27 positive person to have AS. The pronounced discrepancies can be explained by the different selection criteria used in these studies. Interestingly, the high risk of 20% calculated by Calin and Fries'2 would yield a prevalence of definite AS of 1-1*5% in the general population, while the 0-3-3% chance estimated by Christiansen and coworkers'6 would give a prevalence of less than 0-04%. Since the prevalence of AS tends roughly to correlate with the prevalence of B27 in the general population, it is inappropriate to say that the prevalence of AS observed in northern Norway (frequency of B27=15.9%) is similar to that reported by Calin and Fries'2 (frequency of B27=6-8%). Apart from the difference in estimated risks in B27 positives it should be noted that the prevalence rate of AS suggested by Calin and Fries'2 was based on a 6% prevalence of AS among their B27 negative subjects, which is an extremely high prevalence when compared with the risk of0.2% in B27 negatives calculated in the present population survey.
Because of its low specificity, testing for HLA-B27 has been regarded as of little value in the diagnosis of AS.
To a certain extent we agree with these conclusions, as only 6-7% of B27 positive persons in our population had AS. However, in persons with low back pain a higher risk (22.5%) was calculated, indicating a higher diagnostic value of the B27 test than previously suggested.37 38 To conclude, the survey indicated that the prevalence of definite AS is much higher than previously thought and that the male preponderance of AS, though indeed present, appears less pronounced than generally accepted.
